Atea Pharmaceuticals Inc AVIR

$5.13 +0.03 (0.59%)

Valuation

Market cap
409,046,000
Revenue TTM
$0
Net income TTM
$-158,350,000
PE ratio
0.00
Forward PE
—
Profit margin
0.00%
Debt to equity
0.00

Trading

Volume
253,200
Avg volume
315,428
Day's range
$5.05 – $5.22
Shares out
80,205,000
Stochastic %K
28%
Beta
0.39
Analysts
Sell
Price target
$8.50

Price

Company profile

Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes oral antiviral therapeutics for patients with serious viral infections. Its lead product candidate is the regimen of bemnifosbuvir, a nucleotide NS5B inhibitor, and ruzasvir, an NS5A inhibitor, which is in Phase 3 clinical trial for the treatment of hepatitis C virus (HCV). The company also developing AT-58...

Show more

Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes oral antiviral therapeutics for patients with serious viral infections. Its lead product candidate is the regimen of bemnifosbuvir, a nucleotide NS5B inhibitor, and ruzasvir, an NS5A inhibitor, which is in Phase 3 clinical trial for the treatment of hepatitis C virus (HCV). The company also developing AT-587, that is in Phase 1 clinical trial for the treatment of chronic HEV infection. In addition, it offers a proprietary platform of nucleosides and nucleotides for virology, medicinal chemistry, and antiviral drug development. The company has a license agreement with MSD International GmbH for the development, manufacture, and commercialization of ruzasvir. Atea Pharmaceuticals, Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.

Industry
Biotechnology
Sector
Healthcare
Phone
857 284 8891
Website
https://ateapharma.com
Address
225 Franklin Street, Suite 2100, Boston, United States

Latest news

Stocktwits

Navier_Stokes Sep 16, 3:13 PM
$AVIR Icarus flew too close to the sun apparently and a FUDster has entered our quiet community chat.
0 replies
Expharmaguy Sep 15, 10:11 PM
$AVIR Spent some time doing DD on this ticker. Sorry bulls, its a no for me. Good luck
0 replies
Navier_Stokes Sep 8, 8:55 PM
$AVIR Underpriced, unknown to the market masses , under appreciated yet with a provenance that includes a very successful USA and Canada Phase 3 result and waiting for rest of world Global Phase 3 results $AVIR does not trade much over a penny stock. Let that sink in. Penny stock hitting range with a phase 3 positive result in a compelling profitable area of treatment. What’s up with that?
0 replies
Cutlass Sep 8, 1:21 PM
$AVIR HALT please, trades below cash 😄
0 replies
Cutlass Sep 8, 11:09 AM
$AVIR Double on deck here - overall a solid year up 61% YTD 🍒
0 replies
laaarsas Sep 4, 2:24 PM
$AVIR haha!! Grinding higher!! Like I said many before!!
0 replies
laaarsas Sep 3, 6:51 PM
$AVIR Good trend here. Was the correct move so far to hold.
0 replies
TooMuchFinesse Aug 28, 1:23 PM
$AVIR $CMPS $CMPX $PMVP $VIR I’m pretty good at this Bio tech thing 😅✅💰
0 replies